Alex Rothman (@alex_rothman) header
Alex Rothman (@alex_rothman) profile picture

fascinated

Joined August 2014
Photo by Alex Rothman (@alex_rothman)Photo by Alex Rothman (@alex_rothman)Photo by Alex Rothman (@alex_rothman)Photo by Alex Rothman (@alex_rothman)Photo by Alex Rothman (@alex_rothman)Photo by Alex Rothman (@alex_rothman)Photo by Alex Rothman (@alex_rothman)Photo by Alex Rothman (@alex_rothman)Photo by Alex Rothman (@alex_rothman)Photo by Alex Rothman (@alex_rothman)
Remote monitoring in pulmonary arterial hypertension provides the capacity to collect more accurate and more frequent data, enabling novel study designs and potentially informing both clinical studies and practice @alex_rothman @mark_toshner bit.ly/ERSM109
4
1
12
3,137
Positioning Imatinib for Pulmonary Arterial Hypertension: A Dose-Finding Phase 2 Study @atscommunity #PAH 🔓Open Access 🔗atsjournals.org/doi/full/10.…
7
13
1,525
Love this sub stack on our Imatinib trial. The author completely ‘gets’ the big implications of our neat, nimble design. @alex_rothman @MRC_BSU @SofiaSVillar1 drugdevelop.substack.com/p/s…
3
1
10
1,065
Best of #BCS2025. Catching up with friends for some great sessions
1
2
18
927
Supporting fantastic trainees
1
3
137
and the joyous WIC dinner
5
128
And the BCS Young Investigators award winner is Dan Taylor ! @drmorriscardio @ShefUni_ClinMed @insigneo
3
3
16
674
Congratulations to Prof Alexander Rothman who has received the Michael Davies Early Career Award at #BCS2025. We’re so proud to have been part of your research journey as you continue develop more accessible and empowering ways to treat people with Pulmonary Hypertension.
1
2
11
1,990
Packed house for the BCS Young Investigators session - fantastic presentations !
1
2
16
921
Alex Rothman retweeted
In the latest issue! Therapeutic potential of allosteric HECT E3 ligase inhibition dlvr.it/TKqmbX
1
11
52
10,668
The pulmonary artery denervation clinical study using the gradient denervation system in heart failure patients with pulmonary hypertension group 2 – watch the #HFASnacks where Julio Nunez Villota and @dana_dawson16 along with host @slumberbell discuss it. Only at #HeartFailure2025 #HFA_ESC @HFA_President
1
17
2
30
6,322
Can Pulmonary Artery Denervation reshape the future of group 2 PH management? @YulNunezVill presents promising early data on #PADN using the Gradient Denervation System in HF patients with Group 2 PH: 📍 #PADN led to ⬆️ in pulmonary hemodynamics & ⬇️ #RV afterload in combined pre- & post-capillary #PH🫁 📍 Echo parameters showed structural changes consistent with RV unloading 📍 Ongoing studies will confirm these encouraging early findings #HeartFailure2025 #HFA_ESC @escardio #LBCT
2
22
1
46
5,242
Great to be at my first ARCP as dTPD for cardiology in South Yorkshire yesterday. Such world class cardiology talent being nurtured in the steel city & it’s surrounds. @VarianFrances @DrMarkMills @RyanCrapper @drfmejaz @RebeccaGosling3 & others.
1
2
17
1,218
Of the estimated 20,000 human gene products ~4,400 are thought to modify human disease. But if your protein isn’t one of the ~650 targeted by approved therapies…how do you drug it❓Out today @CellCellPress cell.com/cell/fulltext/S0092…
1
6
3
9
3,269
Thanks to all the amazing people⭐️and⭐️funders who have helped this happen 🙏
1
1
184